Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,220.00
Bid: 2,200.00
Ask: 2,240.00
Change: -40.00 (-1.79%)
Spread: 40.00 (1.818%)
Open: 2,220.00
High: 2,220.00
Low: 2,200.00
Prev. Close: 2,240.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

12 Nov 2019 07:00

RNS Number : 0390T
Craneware plc
12 November 2019
 

12 November 2019

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

Appointment of Chairman

 

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, will hold its Annual General Meet today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

We have made good progress in the first four months of the year, continuing to sign the contracts that were delayed from the second half of the previous year and progressing towards the successful conclusion of the remainder. Our Value Cycle strategy and the Trisus platform continue to resonate within the C-suite of US hospitals allowing us to deepen our relationship with our customers. Our sales pipeline continues to grow with opportunities across hospitals of all sizes, for our core Chargemaster Toolkit and Pharmacy ChargeLink products, as well as our new cloud-based Trisus solutions. Results are in line with management expectations and we look forward to providing a greater level of detail within our Interim Results.

 

Appointment of Chairman

 

As announced in our Final Results in September, our long-standing Chairman George Elliott has decided to step down from his position on the Board of Craneware. George has been a fantastic support to me, the Board and the business as a whole. Joining us just prior to our IPO, he has overseen tremendous growth in the company during his tenure and will be missed by us all. He hands on the baton for the next leg of our journey, as we aim to make the Trisus platform ubiquitous in hospitals throughout the United States. We wish him all the very best for the future and personally from me "tight-lines".

 

George will be succeeded in the role of Chairman by Will Whitehorn, who will join us as Chairman of the Board from 1 January 2020. We are delighted to have secured an individual of his calibre. Will joined Virgin in 1986 where he established a career as Sir Richard Branson's corporate affairs advisor and brand development director for the group globally. He helped develop Virgin Atlantic, Virgin Trains and Virgin Media as businesses and went onto become the first President of Virgin Galactic taking the business from a dream to reality. He is currently Chairman of Good Energy Group plc and Deputy Chairman of Stagecoach Group plc, as well as previously being a non-executive director of both Purplebricks Group plc and GVC Holdings plc.

 

Commenting on his appointment, Will Whitehorn said, "I am delighted to be joining Craneware. It has a fantastic platform for growth which continues to have great prospects to develop new opportunities in its core US markets and is led by a strong team, who I am very much looking forward to working with over the coming years."

Outlook

 

The ongoing transition to value-based care is a powerful underlying driver for our software. We are committed to providing our customers with the tools they require to continue to deliver outstanding care to their communities and are passionate about the central role we will play in this substantial evolution of the US healthcare market. We remain focused on the delivery of our growing opportunity and confident we have the correct strategy to succeed.

 

Director Appointment Information

 

Directorships of William Elliott Whitehorn, aged 59

 

Current:

Within the last 5 years:

Stagecoach Group plc

GVC Holdings plc

Good Energy Group plc

Purblebricks Group plc

AAC Clyde Space AB

Clyde Space Ltd

AAC Microtec UK Ltd

Transport Systems Catapult Ltd

The Scottish Gallery (Aitken Dott Ltd)

Transport Systems Catapult Services Ltd

Scottish Event Campus Ltd

STFC Innovations Ltd

Will Whitehorn Consultancy Ltd

Crowd Reactive Ltd

The Royal Air force Main Board

Speed Communications Agency Ltd

West End Media Partnership

Jubilee Film Partnership LLP

Illustrated London News Limited

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 For further information, please contact:

 

Craneware plc

Peel Hunt (NOMAD & Joint Broker)

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Hilary Buchanan

Guy Pengelley

Henry Reast

Helena Bogle

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMBCBDBSXBBGCB
Date   Source Headline
28th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:14 pmRNSDividend Currency Election
21st Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSInterim Results
17th Jan 20247:00 amRNSTrading Update and Notice of Results
14th Dec 20234:29 pmRNSNotification of Major Holdings
12th Dec 20232:36 pmRNSNotification of Major Holdings
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSDividend Currency Election
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20236:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Statement
1st Nov 20232:38 pmRNSExercise of SAYE Options, Director Dealing & TVR
25th Oct 20237:00 amRNSDirector Share Purchase
17th Oct 20236:10 pmRNSPosting of Annual Report and Notice of AGM
17th Oct 20239:44 amRNSExtension of share buyback programme
17th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSBlock listing Interim Review
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.